GREATER CHINA Economics PMI A strong rebound for non-manufacturing PMI. Sector Macau Gaming Dec 24 GGR below expectations; expect 2025 GGR to recover to 82% of 2019’s level. INDONESIA Update Mitra Keluarga Karyasehat (MIKA IJ/BUY/Rp2,540/Target: Rp3,300) Expect a double-digit earnings growth in 2025 MALAYSIA Sector Heal...
The tone from the analyst meeting for reviewing BCH’s 3Q24 earnings was neutral. We are seeing positives such as the decent earnings growth and the favourable conclusion of the AdjRW>2 rate for next year. However, the reduction of AdjRW>2 for this year is still a potential downside. We are optimistic about BCH, as growth from SSO patients is expected to be strong next year, with several hospitals reopening after renovations. Maintain BUY. Target price: Bt20.00.
GREATER CHINA Economics PMI Manufacturing PMI Edges Up, Non-Manufacturing Still Under Pressure. Sector Macau Gaming Nov 24 GGR Down 11% Mom After A Strong Golden Week; More Policies To Support Macau Visitations. Results Meituan (3690 HK/BUY/HK$168.70/Target: HK$222.00) 3Q24: Solid earnings beat; 4Q24 out...
BCH reported a net profit of Bt453m in 3Q24 (+2.9% yoy, +63.6% qoq) which is in line with our and consensus forecasts. BCH did a decent job in compensating the decline in IPD revenue caused by the absence of Kuwait patients and posted a soft yoy revenue growth in 3Q24. We are optimistic about BCH as the AdjRW>2 rate is likely to be settled in a way that benefits BCH, and there is clear potential for growth from the new cancer centre. Maintain BUY. Target price: Bt20.00.
KEY HIGHLIGHTS Results Amata Corporation (AMATA TB/BUY/Bt23.50/Target: Bt35.00) 3Q24: Net income missed expectations but still skyrocketed yoy and qoq. Bangkok Chain Hospital (BCH TB/BUY/Bt16.10/Target: Bt20.00) 3Q24: Mild growth. Central Pattana (CPN TB/BUY/Bt60.00/Target: Bt84.00) 3Q24: Results in line; well-positioned to close 2024 with a new record high. Central Plaza Hotel (CENTEL TB/SELL/Bt33.00/Target: Bt47.00) 3Q24: Better-than-expect...
We expect BCH to report a net profit of Bt451m in 3Q24 (+2.3% yoy, +62.7% qoq). The main contributor is the increase of OPD patients during the rainy season. Going forward, we are optimistic on BCH as the conclusion of the AdjRW>2 rate issue is likely to be beneficial for BCH, and there is also visible upside from the new cancer centre. Maintain BUY. Target price: Bt20.00.
KEY HIGHLIGHTS Strategy Impact from Trump’s Policies Foresee a robust outlook for the industrial estate and electronics sectors due to the US-China trade war. Our top picks are AMATA, BANPU, DELTA, STGT and WHA. Results PTT Global Chemical (PTTGC TB/HOLD/Bt26.25/Target: Bt24.50) 3Q24: Net loss of Bt19.3b due to huge impairment loss. Quality Houses (QH TB/HOLD/Bt1.85/Target: Bt1.82) 3Q24: In l...
BCH’s operations have normalised after experiencing earnings fluctuations during the COVID-19 outbreak. Management has revised down the revenue growth guidance for 2024 as a result of pressure from several factors. However, we are cautiously optimistic on BCH as there is a huge upside to the stock if it is able to become an operator of choice for Kuwait patients. Upgrade to BUY. Target price: Bt19.00.
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: We expect an improving operating performance among selected companies in September, and add AIA, COLI, Desay SV, Galaxy Entertainment, Meituan, Ping An and TUL to our BUY list and add Li Auto as a SELL. Update Shenzhou International Group Holdings (2313 HK/BUY/HK$62.55/Target: HK$96.50): Shenzhou NDR Takeaways: Expect 10% volume growth and a flat ASP in 2H24. INDONESIA Update Bank Rakyat Indonesia (BBRI IJ/HOLD/Rp5,100/Target: Rp5,...
GREATER CHINA Strategy Small-Mid Cap Monthly Reiterate BUY on Plover Bay Technologies. Sector Automobile Weekly: Sales of top 12 EV brands up 38% wow last week, in line. Maintain MARKET WEIGHT. Top BUYs: Geely, CATL and Tuopu. Top SELL: XPeng. INDONESIA Update Sarana Menara Nusantara (TOWR IJ/BUY/Rp745/Target: Rp890) Number of towers to jump 10% on a...
We expect BCH’s 2Q23 earnings to improve qoq from distressing 1Q23 results due to a basic capitation rate increase by SSO, a small wave of COVID-19 infections and the recovery of international patients in May-Jun 23. We expect an improvement in 2H23, which is the high season. Margin pressure is expected to persist due to weak performances from new investments, although the market has reflected this concern to a considerable extent. Upgrade to HOLD. Target price: Bt17.30.
KEY HIGHLIGHTS Update Bangkok Chain Hospital (BCH TB/HOLD/Bt17.80/Target: Bt17.30) 2Q23 results preview: Modest qoq improvement on SSO rate hike. Plan B Media (PLANB TB/BUY/Bt8.35/Target: Bt9.40) Positive yoy and qoq earnings growth in 2Q23 on robust utilisation rate.
GREATER CHINA Strategy Small-Mid Cap Biweekly: Gold prices denominated in CNY topped out at a year-high level; Beneficiaries: Shandong Gold and Luk Fook. Sector Commodities: Weekly: Awaiting signals from US FOMC and China Politburo meetings. Update Sino Biopharmaceutical (1177 HK/HOLD/HK$3.43/Target: HK$3.70): Expects 1H23 revenue to be flat from 1H22; lowers 2023 revenue growth guidance to single digits. INDONESIA Sector Property: Robust 1H23 pre-sales achievement; shares continue to outperfor...
BCH posted a negative surprise in 1Q23 net profit at almost 20% lower than consensus estimate, with earnings not only normalised to pre-COVID-19 level but below pre- COVID-19 level on margin contraction. Although we expect the margins to improve qoq in the next three quarters, they are foreseen to be low as expenditures rise. Downgrade to SELL. Target price: Bt17.30.
KEY HIGHLIGHTS Results Bangkok Chain Hospital (BCH TB/SELL/Bt18.80/Target: Bt17.30) 1Q23: A shocking earnings surprise to the downside on slumped margins. Downgrade to SELL Bangkok Dusit Medical Services (BDMS TB/BUY/Bt29.75/Target: Bt33.00) 1Q23: Earnings hit a new record high on robust revenue and margins. Upgrade to BUY. Bangkok Expressway and Metro (BEM TB/HOLD/Bt9.05/Target: Bt9.80) 1Q23: Earnings beat on lower-than-expected expenditure. GFPT (GFPT TB/BUY/Bt11.20/Target: Bt13.20) 1Q2...
GREATER CHINA Economics Inflation: Headline inflation lower; core holds steady. Money Supply: Liquidity remains ample, but households delevered. Sector Automobile: Weekly: April car sales beat; further recovery in the first week of May. Maintain UNDERWEIGHT. Top BUYs: BYD, Li Auto and CATL. Internet: Cloud industry development facilitated by recent AIGC breakthrough. Results JD.com (9618 HK/BUY/HK$135.00/Target: HK$216.00): 1Q23: Earnings beat; soft 2Q23 top-line growth. INDONESIA Sector Proper...
BCH’s 1Q23 earnings are expected to be relatively flat from the absence of significant catalysts, despite there being fewer one-off items than in 4Q22. We are mildly optimistic going into 2Q-4Q23 as there will be an increase in basic capitation rate by SSO and continuous growth from BCH’s existing hospitals. Maintain BUY. Target price: Bt24.00.
KEY HIGHLIGHTS Sector Banking 1Q23 results wrap-up: Results beat on investment gains; selective BUY on banks that are still laggards. Results Delta Electronics (DELTA TB/SELL/Bt888.00/Target: Bt660.00) 1Q23: Earnings missed our expectations; weak outlook not over yet. Update Bangkok Chain Hospital (BCH TB/BUY/Bt21.70/Target: Bt24.00) Expect 1Q23 net profit to be flat; positive earnings outlook for 2023.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.